paloma manea, md,phd,faccp, lecturer, … · 2017-02-01 · comparison between hs-c reactive...

31
COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION RENOVASCULAR HYPERTENSION Paloma Manea, MD, PhD, FACCP, Lecturer, “GrigoreT.Popa”University of Medicine and Pharmacy, Iasi, Romania “Promedicanon” Private Office, Iasi

Upload: others

Post on 24-Feb-2020

5 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

COMPARISON BETWEEN HS-C REACTIVE

PROTEIN AND MICROALBUMINURIA

LEVELS FOR THE PROGNOSIS OF

RENOVASCULAR HYPERTENSIONRENOVASCULAR HYPERTENSION

Paloma Manea, MD, PhD, FACCP,

Lecturer, “GrigoreT.Popa” University of

Medicine and Pharmacy, Iasi, Romania

“Promedicanon” Private Office, Iasi

Page 2: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

HISTORY OF RAA SYSTEM

1. 1898: Tigerstedt RENIN discovery

kidney extract rabbits hypertension

Page 3: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

HISTORY OF RAA SYSTEM

2. 1934 Goldblatt experimental renovascular hypertension

clampation of renal arteries hypertension

(dogs)

Page 4: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

HISTORY OF RAA SYSTEM

3. 1939 Braun- Menendez ANGIOTENSIN

renin

angiotensinogen angiotensin

Page 5: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

HISTORY OF RAA SYSTEM

4. 1993 Skeggs ANGIOTENSIN I , II

ACE

angiotensin I angiotensin II

hypertension

Page 6: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

INTRODUCTION

1.Renovascular hypertension diagnosis trap

2.Life threatening complications ( after ACEI !)

Dr. Paloma Manea ‘s collection

Page 7: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

INTRODUCTION

3.Modern therapy DISCORDANCE Practical reality

Page 8: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

PURPOSES

hsCRP / microAuria: prognosis markers + therapeutic implications

MATERIALS AND METHODS

76 patients ,43- 86 years , 67% males , renovascular hypertension, 24 months

1. Clinical examination : quarterly

- exclusion criteria : - actually smoker/ alcohol drinker

- evolutive neoplasia

- autoimmune disorders

- diabetes mellitus- diabetes mellitus

- obesity

- active infection

- inclusion criteria:

-difficult control of hypertension

-paradoxical hypertension after ACEI

-periumbilical bruits

clipartbest.com

Page 9: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

MATERIALS AND METHODS

2. EKG , quarterly: - standard 12 leads EKG - LVH

3. Ecocardiogram : -transthoracic, M mode, 2D mode

-color Doppler; continuous Doppler

LVH, LV mass, LV performance

Page 10: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

MATERIALS AND METHODS

4. Renal artery sonogram

peak velocity , resistivity index

5. Abdominal computed tomography angiogram

if sonogram ≠ clear

6. Laboratory findings : quarterly6. Laboratory findings : quarterly

Creatinine clearance, hs-C Reactive Protein, microAuria

7.M -Indapamide 1.5 mg, Amlodipine 5-10mg, Nebivolol 5-10 mg

-Atorvastatin 10-40 mg, Rilmenidine 1-2 mg

-Aspirin 100 mg/ Clopidogrel 75 mg/Acenocumarol 1-4 mg

8. Interventional : percutaneous angioplasty + stenting(RI < 0.8)

9.Dental treatment: scaling of dental plaque(biannual)

Page 11: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

Dental plaque bacteria (Porphyromonis gingivalis)

1. Interleukin 1 atheromatous plaque formation

2. Interleukin 6 CRP atheromatous plaque disruption

3. Repeated bacteriemia atheromatous plaque inflamation

Page 12: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

RESULTS

1. Clinical examination:

25

30

35

40

45

0

5

10

15

20

25

Periumbilical bruits Paradoxical hypertension after

ACEI

Dificult control of

hypertension

Page 13: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

RESULTS

2. EKG- LVH : 68 patients (89%)

Dr. Paloma Manea’s collection

Page 14: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

RESULTS

3.Echocardiography:

-LVH (wall thickness, mass)

Dr. Paloma Manea’s collection

Page 15: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

RESULTS

3. Echocardiography: - 19% diminished LVH (mass)

- 94%(1m) 75%(24m)

19%

20

30

40

50

60

70

80

Evolution of LVH mass during 24 months observation

0

10

20

3 m6 m

12 m15 m

18 m21 m

24 m

Page 16: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

RESULTS

3.Echocardiography:

- LV diastolic dysfunction

Dr. Paloma Manea’s collection

Page 17: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

Dr.Paloma Manea’s collection

Page 18: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

20

30

40

50

60

Types of diastolic dysfunction(LV)

0

10

20

type 1 type 2 type 3 type 4

Page 19: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

RESULTS

3.Echocardiography: -34% improved LV diastolic function

-80% (1m ) 54%(24m )

34%

50

60

70

Evolution of LV diastolic dysfunction

0

10

20

30

40

50

3 m6 m

9 m12 m

15 m18 m

21 m24 m

Page 20: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

RESULTS

3. Echocardiography:

- LV systolic dysfunction : segmentary kinetics

Dr.Paloma Manea’ s collection

Page 21: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

RESULTS

3. Echocardiography : -28% improved LV EF (EF>30%)

-51%(1m ) low EF 23% (24m)

28%

10

20

30

40

Evolution of significant LV systolic dysfunction (EF< 30%)

0

10

3 m 6 m

9 m12 m

15 m18 m

21 m24 m

Page 22: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

RESULTS

4. Renal arteries sonogram:

Dr.Corina Ursulescu’ s and Dr.Dragos Negru ‘s collection

Page 23: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

RESULTS

4. Renal arteries sonogram:

Dr.Corina Ursulescu’ s and Dr.Dragos Negru ‘s collection

Page 24: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

RESULTS

4. Renal arteries sonogram:

Dr.Corina Ursulescu’ s and Dr.Dragos Negru ‘s collection

Page 25: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

RESULTS

5.Abdominal computed tomography angiogram: 16 pts(21%)

Dr.Corina Ursulescu’s and Dr. Dragos Negru’s collection

Page 26: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

RESULTS

5.Abdominal computed tomography angiogram

Dr.Corina Ursulescu’s and Dr. Dragos Negru’s collection

Page 27: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

RESULTS

6. Laboratory findings:- 25% improved Creatinine clearance

- 53% (1m) low Cr clearance 28% (24m)

25%

50

Evolution of reduced Creatinine clearance

0

10

20

30

40

50

3 m 6 m

9 m12 m

15 m18 m

21 m24 m

Page 28: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

RESULTS

6. Laboratory findings:-48% diminished hs CRP (24m)

-high hsCRP 78%( 1m) 30% (24 m)

48%

-30% high hs CRP/ 28% low Creatinine clearance(p=0.006)

Evolution of pathological hs-CRP values

0

20

40

60

80

3 m6 m

9 m12 m

15 m18 m

21 m24 m

Page 29: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

RESULTS

6.Laboratory findings :-12% diminished microA uria(24m)

-micro A uria 58%(1m) 46%(24 m)

12%

-46% micro Auria / 28% low Creatinine clearance (p=0.004)

60

Evolution of pathological micro Auria

0

20

40

60

3 m6 m

9 m12 m

15 m18 m

21 m24 m

Page 30: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

CONCLUSIONS

1. After 24 m: -improved LV EF 28%

-improved LV diastolic function 34%

-diminished LVH (mass) 19%

-improved Creatinine clearance 25%

-diminished hs CRP 48%

-diminished microA uria 12%

2. hs CRP = a better prognosis marker then microAuria

30% high hs CRP / 46% microAuria / 28% low Creatinine clearance

3. Originality : dental treatment renovascular hypertension prognosis

4. Future direction: analysis of the renal artery atheromatous plaque( biopsy)

Page 31: Paloma Manea, MD,PhD,FACCP, Lecturer, … · 2017-02-01 · COMPARISON BETWEEN HS-C REACTIVE PROTEIN AND MICROALBUMINURIA LEVELS FOR THE PROGNOSIS OF RENOVASCULAR HYPERTENSION Paloma

ACKNOWLEDGEMENTS

1. Dr. Corina Ursulescu, Lecturer, Specialist in Radiology

2. Dr. Dragos Negru, Professor, Senior in Radiology

3. Dr. Irina Asandei, Specialist in Laboratory Medicine

4. Dr. Igor Nedelciuc , Specialist in Interventional Cardiology